ResultsIQ

ResultsIQ › Latest results › Royal Orchid Hotels Limited

Royal Orchid Hotels Limited Q4 FY25 earnings call summary

NSE: ROHLTD · BSE: 532699

Earnings call of 6 Jun 2025, summarised by AI from the filing.

Revenue ₹92.34 cr up 12% year-on-year; EBITDA ₹25.52 cr up 7%; PAT before exceptional items ₹13.15 cr.

Key takeaways

  1. Q4 FY25 results Revenue ₹92.34 cr up 12% year-on-year; EBITDA ₹25.52 cr up 7%; PAT before exceptional items ₹13.15 cr.
  2. Brand architecture Five brands from Regenta Zed to ICONIQA; no more Royal Orchid Hotels will come up.
  3. Margin volatility Margins volatile over last four years due to cost escalations and refurbishment investments written off.

Original filing on BSE

Royal Orchid Hotels Limited Q1 FY27 results

As filed: Revenue ₹107 cr (+36% year on year), EBITDA ₹25.4 cr (+27% year on year), PAT ₹6.8 cr (−38% year on year), EBITDA margin 23.7% (−159 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹113 cr (+30% year on year), EBITDA ₹1.1 cr (−94% year on year), PAT ₹8.2 cr (−57% year on year), EBITDA margin 1.0% (−1,000 bps). Score 26 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 1000 bps year on year. Other income 64% of PBT. Consolidated profit -37% but standalone +396%. Profit fell 34% from last quarter. Share price after the results: +0.2% in 30 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹113 cr (+27% year on year), EBITDA ₹29.9 cr (+20% year on year), PAT ₹9.6 cr (−47% year on year), EBITDA margin 26.5% (−160 bps). Score 66 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was well below it. EBITDA margin fell 160 bps year on year. Other income 47% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −14.0% in 30 days (Nifty 500: −7.8%).
  • Q2 FY26: Revenue ₹79.0 cr (+13% year on year), EBITDA ₹13.0 cr (+18% year on year), PAT ₹4.0 cr (−50% year on year), EBITDA margin 16.5% (+74 bps). Score 47 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit growth was well below it. EBITDA margin rose 74 bps year on year. Other income 200% of PBT. Profit fell 64% from last quarter. Share price after the results: −14.9% in 30 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹79.0 cr (+8% year on year), EBITDA ₹20.0 cr (+25% year on year), PAT ₹11.0 cr (+22% year on year), EBITDA margin 25.3% (+340 bps). Score 61 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 340 bps year on year. Other income 27% of PBT. Revenue fell 9% from last quarter. Share price after the results: +23.0% in 30 days (Nifty 500: +2.2%).
  • Q4 FY25: Revenue ₹87.0 cr (+14% year on year), EBITDA ₹19.0 cr (+12% year on year), PAT ₹13.0 cr (−24% year on year), EBITDA margin 21.8% (−53 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was well below it. EBITDA margin fell 53 bps year on year. Other income 38% of PBT. Profit fell 28% from last quarter. Share price after the results: +0.5% in 30 days (Nifty 500: +2.7%).
  • Q3 FY25: Revenue ₹89.0 cr (+9% year on year), EBITDA ₹25.0 cr (0% year on year), PAT ₹18.0 cr (+13% year on year), EBITDA margin 28.1% (−240 bps). Score 51 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 240 bps year on year. Other income 27% of PBT.
  • Q2 FY25: Revenue ₹70.0 cr (+4% year on year), EBITDA ₹11.0 cr (−35% year on year), PAT ₹8.0 cr (0% year on year), EBITDA margin 15.7% (−966 bps). Score 14 of 100, Below trend. EBITDA margin fell 966 bps year on year. Other income 80% of PBT. Not enough history for a trend yet: scored on growth alone. Revenue fell 4% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Royal Orchid Hotels Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.